Zaida Morante
Biographic Data
| ID | 7983844 |
|---|---|
| NAME | Zaida Morante |
| GIVEN NAMES | Zaida |
| FAMILY NAME | Morante |
| SIGNATURE | MORANTE Z |
| AFFILIATIONS | Instituto Nacional de Enfermedades Neoplásicas |
| ORCID | 0000-0003-2952-6068 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2018 |
| H-INDEX | 0 |
Anemia como factor pronóstico en pacientes con cáncer
Anemia is common in cancer patients, and its presence determines an independent prognostic factor in overall survival
Citorreducción óptima en cáncer de ovario avanzado tratado con paclitaxel a dosis densa y carboplatino seguido de cirugía de intervalo en el Instituto Nacional de Enfermedades Neoplásicas del Perú
Neoadjuvant therapy with dose-dense carboplatin and paclitaxel achieved an elevated frequency of optimal cytoreduction. The post-surgery levels of carcinoembryonic antigen 125 and optimal cytoreduction were independent factors of progression-free survival and overall survival
No prominent works on this page.
Anemia como factor pronóstico en pacientes con cáncer
Anemia is common in cancer patients, and its presence determines an independent prognostic factor in overall survival
Citorreducción óptima en cáncer de ovario avanzado tratado con paclitaxel a dosis densa y carboplatino seguido de cirugía de intervalo en el Instituto Nacional de Enfermedades Neoplásicas del Perú
Neoadjuvant therapy with dose-dense carboplatin and paclitaxel achieved an elevated frequency of optimal cytoreduction. The post-surgery levels of carcinoembryonic antigen 125 and optimal cytoreduction were independent factors of progression-free survival and overall survival
Internal Medicine (2 works) · Medicine (2 works) · Anemia (1 work) · Cancer (1 work) · Carboplatin (1 work) · Carcinoembryonic antigen (1 work) · Chemotherapy (1 work) · Cisplatin (1 work) · Debulking (1 work) · Erythropoietin and Anemia Treatment (1 work)